Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This prospective phase II study is to determine the efficacy and safety of bevacizumab
maintenance therapy after concurrent chemoradiotherapy in locally advanced lung
adenocarcinoma